why choose us

First received: October 21, 2024

Clinical Trial: Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Bladder (Urothelial, Transitional Cell) Cancer

Study Type: OBSERVATIONAL


Official Title: A Study to Evaluate ENPP1 Expression and Its Role in Immune Evasion and Chemoresistance in Bladder Cancer

Brief Summary: This study aims to investigate the role of ENPP1 in bladder cancer (BC), specifically focusing on its impact on immune evasion, chemoresistance, and prognosis.The study will analyze gene expression data from clinical samples and use various laboratory techniques, including RNA sequencing, qRT-PCR, and immunohistochemistry, to assess ENPP1's expression levels.In addition, the research will explore the relationship between ENPP1 and immune cell infiltration, along with its correlation with patient survival…

Read more